Samsung NEXT

Samsung NEXT is an innovation group within Samsung Electronics that focuses on identifying and pursuing new growth opportunities. Through Samsung NEXT Ventures, it acts as the company’s venture capital arm, investing in early-stage startups and technologies with potential to redefine multiple industries. The group targets areas including artificial intelligence, fintech, blockchain, health technology, infrastructure, media technology, software, and related fields such as robotics and drones. By combining internal startup acceleration with external investments, Samsung NEXT aims to accelerate technology adoption and create scalable platforms that complement Samsung’s hardware and software ecosystems.

Sam Campbell

Investor

Carlos Castellanos

Venture Capitalist

Leo Chang

Principal

Andy Duong

Principal

Lizzy Goldman

Investor

Antonio Key

Investor

Brendon Kim

Managing Director | Vice President | Head of Investments

Joan Kim

Investor

Emily Koster

Director of Communications

Amy Lee

Investor

Raymond Liao

Managing Director

Jonathan Machado

Investor

Yonatan Machado

Senior Investment Director

Eyal Miller

Vice President

Nick Nigam

Principal, Seed to Series B Venture Capital Investments

Caroline Rehfuss

Investor

John Rodkin

Managing Director

Past deals in Wearables

Afference

Seed Round in 2024
Afference specializes in wearable electronics, focusing on innovative technologies that bridge the gap between digital and physical experiences. Their core product enables users to interact with various devices such as VR, AR, and gaming consoles through advanced neural stimulation, providing tactile feedback.

Forward

Series E in 2023
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Signos

Series B in 2023
Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Ixana

Seed Round in 2022
Ixana is a company specializing in wearable hardware technology. It focuses on developing innovative human-computer interfaces.

Genopets

Seed Round in 2022
Genopets is a Solana-based move-to-earn NFT mobile game where a digital pet evolves in tandem with the player's real-world activity. A Genopet's growth and abilities are powered by steps tracked from smartphones and wearables, fueling gameplay in the Genoverse that includes exploration, battles, and evolution, while players earn cryptocurrency rewards. The game links daily activity to a bond with the digital companion and self-care, drawing on Tamagotchi-like care and Pokémon-inspired progression to motivate ongoing activity. By integrating wearable data with blockchain-based NFTs, Genopets delivers a persistent experience in which physical effort translates into in-game value.

Aviron

Seed Round in 2021
Aviron specializes in premium home fitness equipment, notably its connected rowing machine. This machine offers gamification features, high-intensity workouts, strength training options, and diverse content to keep users motivated and engaged.

Terra API

Seed Round in 2021
Terra facilitates seamless health data exchange. It connects applications with various wearables, sensors, and blood labs.

Huma

Series C in 2021
Huma is a global health technology company that provides a modular platform to support digital hospitals at home across disease areas. The platform combines predictive algorithms, digital biomarkers, and real-world data to enable proactive and predictive care and research. It integrates data from hospital databases, patient wearables, and mobile devices to deliver real-time information to healthcare providers, supporting connected care. Through collaborations with leading healthcare institutes, Huma uses data and clinical expertise to measure outcomes and accelerate research and therapies, helping clinicians deliver better patient care.

HealthifyMe

Series B in 2018
HealthifyMe is a mobile and web-based health and fitness platform that helps users achieve fitness and weight management goals by tracking calories, nutrition, and physical activity. The app allows users to monitor weight, set healthy targets, and share data with nutritionists and fitness professionals for expert guidance. It features an AI-powered fitness coach that uses automated analytics to analyze food intake and activity, delivering personalized recommendations and progress insights. Founded in 2012 by doctors, nutritionists, and fitness trainers, HealthifyMe is based in Bangalore, India. In addition to consumer tools, the platform supports corporate wellness by offering online fitness consultations and tailored health programs for organizations.

HealthifyMe

Series B in 2018
HealthifyMe is a mobile and web-based health and fitness platform that helps users achieve fitness and weight management goals by tracking calories, nutrition, and physical activity. The app allows users to monitor weight, set healthy targets, and share data with nutritionists and fitness professionals for expert guidance. It features an AI-powered fitness coach that uses automated analytics to analyze food intake and activity, delivering personalized recommendations and progress insights. Founded in 2012 by doctors, nutritionists, and fitness trainers, HealthifyMe is based in Bangalore, India. In addition to consumer tools, the platform supports corporate wellness by offering online fitness consultations and tailored health programs for organizations.

Glooko

Series C in 2017
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Glooko

Series C in 2016
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Glooko

Series B in 2015
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

BioBeats

Seed Round in 2015
BioBeats, established in 2012 and headquartered in London, specializes in digital health solutions for personal wellness. The company leverages artificial intelligence and real-time data from smartphones and wearables to tackle global mental health challenges. By fusing research from the University of Oxford, BioBeats creates AI products that track neurological and physiological correlates to psychological progress, predict disorder onset, and provide personalized support. Their psychological wellness application calculates a baseline wellbeing score and offers insights into stress responses, enabling users to identify harmful patterns and improve their overall mental health.

Glooko

Series A in 2014
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.